Your browser doesn't support javascript.
loading
Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
Andrews, Michael; Yoshida, Teruhiko; Henderson, Clark M; Pflaum, Hannah; McGregor, Ayako; Lieberman, Joshua A; de Boer, Ian H; Vaisar, Tomas; Himmelfarb, Jonathan; Kestenbaum, Bryan; Chung, Joon-Yong; Hewitt, Stephen M; Santo, Briana A; Ginley, Brandon; Sarder, Pinaki; Rosenberg, Avi Z; Murakami, Taichi; Kopp, Jeffrey B; Kuklenyik, Zsuzsanna; Hoofnagle, Andrew N.
Afiliação
  • Andrews M; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Yoshida T; Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Henderson CM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
  • Pflaum H; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
  • McGregor A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
  • Lieberman JA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.
  • de Boer IH; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Vaisar T; Kidney Research Institute, University of Washington, Seattle, Washington, United States of America.
  • Himmelfarb J; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Kestenbaum B; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Chung JY; Kidney Research Institute, University of Washington, Seattle, Washington, United States of America.
  • Hewitt SM; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Santo BA; Kidney Research Institute, University of Washington, Seattle, Washington, United States of America.
  • Ginley B; Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
  • Sarder P; Center for Cancer Research, NCI, NIH, Bethesda, Maryland, United States of America.
  • Rosenberg AZ; Department of Pathology and Anatomical Sciences, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
  • Murakami T; Department of Pathology and Anatomical Sciences, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
  • Kopp JB; Department of Pathology and Anatomical Sciences, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
  • Kuklenyik Z; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
  • Hoofnagle AN; Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One ; 17(10): e0276649, 2022.
Article em En | MEDLINE | ID: mdl-36279295
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Apolipoproteína L1 Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Apolipoproteína L1 Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article